Milgamma is a drug whose active principle is benfotiamine, a derivative of vitamin B1, an essential substance that plays important roles in the body's metabolism.
Benfotiamine can be used to alleviate vitamin B1 deficiencies caused by excessive alcohol intake and also prevents the damaging consequences of increased glucose levels in diabetic patients.
Milgamma is an oral medication produced by the pharmaceutical company Mantecorp Indústria Química e Farmacêutica.
Indications of Milgamma
Milgamma is indicated for the prevention and treatment of vitamin B1 deficiencies caused by excessive alcoholic beverages, as well as in the treatment of symptomatic polyneuropathy associated with diabetes that manifest mainly in the form of leg tingling pains and sensations in diabetic and alcoholic patients.
Price of Milgamma
The price of Milgamma varies between 15 and 48 reais.
How to use Milgamma
The mode of use of Milgamma consists of the use of 1 tablet of 150 mg Milgamma, 2 to 3 times a day, to dose 300 mg to 450 mg of benfotiamine per day, depending on the severity of the neuropathy, for at least 4 to 8 weeks. After this initial period, the maintenance treatment should be based on the therapeutic response, being recommended the ingestion of 1 tablet per day, corresponding to 150 mg of benfotiamina.
The dosage and dosage of the medicinal product should be indicated by the endocrinologist.
Adverse effects of Milgamma
The adverse effects of Milgamma can be rashes, urticaria, anaphylactic reactions and nausea.
Contraindications of Milgamma
Milgamma is contraindicated for patients with hypersensitivity to any component of the formula, as well as in pregnant and lactating women or individuals under the age of 18 years.
Useful links:
- Peripheral polyneuropathy
- Diabetic neuropathy
- Benflogin
